Sibilano, M.; Tullio, V.; Adorno, G.; Savini, I.; Gasperi, V.; Catani, M.V.
Platelet-Derived miR-126-3p Directly Targets AKT2 and Exerts Anti-Tumor Effects in Breast Cancer Cells: Further Insights in Platelet-Cancer Interplay. Int. J. Mol. Sci. 2022, 23, 5484.
https://doi.org/10.3390/ijms23105484
AMA Style
Sibilano M, Tullio V, Adorno G, Savini I, Gasperi V, Catani MV.
Platelet-Derived miR-126-3p Directly Targets AKT2 and Exerts Anti-Tumor Effects in Breast Cancer Cells: Further Insights in Platelet-Cancer Interplay. International Journal of Molecular Sciences. 2022; 23(10):5484.
https://doi.org/10.3390/ijms23105484
Chicago/Turabian Style
Sibilano, Matteo, Valentina Tullio, Gaspare Adorno, Isabella Savini, Valeria Gasperi, and Maria Valeria Catani.
2022. "Platelet-Derived miR-126-3p Directly Targets AKT2 and Exerts Anti-Tumor Effects in Breast Cancer Cells: Further Insights in Platelet-Cancer Interplay" International Journal of Molecular Sciences 23, no. 10: 5484.
https://doi.org/10.3390/ijms23105484
APA Style
Sibilano, M., Tullio, V., Adorno, G., Savini, I., Gasperi, V., & Catani, M. V.
(2022). Platelet-Derived miR-126-3p Directly Targets AKT2 and Exerts Anti-Tumor Effects in Breast Cancer Cells: Further Insights in Platelet-Cancer Interplay. International Journal of Molecular Sciences, 23(10), 5484.
https://doi.org/10.3390/ijms23105484